Pierre Fabre Laboratories United States of America Canada France Germany Spain United Kingdom

Pierre Fabre Laboratories y Scorpion Therapeutics anuncian administración de dosis de PFL-241/STX-241

View original content:https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-y-scorpion-therapeutics-anuncian-administracion-de-dosis-de-pfl-241stx-241-302270072.html